Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
The mechanism of apoptosis has been extensively characterized over the past decade, but little is known about alternative forms of regulated cell death. Although stimulation of the Fas/TNFR receptor family triggers a canonical 'extrinsic' apoptosis pathway, we demonstrated that in the absence of intracellular apoptotic signaling it is capable of activating a common nonapoptotic death pathway, which we term necroptosis. We showed that necroptosis is characterized by necrotic cell death morphology and activation of autophagy. We identified a specific and potent small-molecule inhibitor of necroptosis, necrostatin-1, which blocks a critical step in necroptosis. We demonstrated that necroptosis contributes to delayed mouse ischemic brain injury in vivo through a mechanism distinct from that of apoptosis and offers a new therapeutic target for stroke with an extended window for neuroprotection. Our study identifies a previously undescribed basic cell-death pathway with potentially broad relevance to human pathologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Necroptosis is a form of RCD initiated by perturbations of the extracellular or intracellular microenvironment detected by specific death receptors, including (but not limited to) FAS and TNFR1 [423–427], or pathogen recognition receptors (PRRs), including TLR3, TLR4, and Z-DNA binding protein 1 (ZBP1; also known as DAI) [428–430].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [425]
In the citing paper
“Accordingly, chemical inhibitors of RIPK1 including necrostatin-1 (Nec-1) and derivatives (e.g., Nec-1s) robustly inhibit TNFR1-driven necroptosis, in vitro and in vivo [425, 427].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [425]
Citations
Cites
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605
Self-citationAutophagy as a Regulated Pathway of Cellular Degradation
Klionsky, D. J., & Emr, S. D. (2000) · Science · doi:10.1126/science.290.5497.1717 · Cited by 3,608 · cited 1×
“Activation of autophagy by necroptotic signaling Autophagy, a large-scale protein degradation and catabolic mechanis”
The role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865 · cited 1×
“4e and data not shown), in autophagy-deficient Atg5 −/− MEF cell”
Self-citationHoller, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J.-L., Schneider, P., Seed, B., & Tschopp, J. (2000) · Nature Immunology · doi:10.1038/82732 · Cited by 1,938
Mechanisms, challenges and opportunities in stroke
Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1106 · Cited by 1,781
Self-citationGrowth factor regulation of autophagy and cell survival in the absence of apoptosis
Lum, J. J., Bauer, D. E., Kong, M., Harris, M. H., Li, C., Lindsten, T., & Thompson, C. B. (2005) · Cell · doi:10.1016/j.cell.2004.11.046 · Cited by 1,487
LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation
Kabeya, Y., Mizushima, N., Yamamoto, A., Oshitani-Okamoto, S., Ohsumi, Y., & Yoshimori, T. (2004) · Journal of Cell Science · doi:10.1242/jcs.01131 · Cited by 1,394
Self-citationAutophagy as a cell death and tumor suppressor mechanism
Gozuacik, D., & Kimchi, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207521 · Cited by 1,384 · cited 1×
“, has been implicated in caspase-independent cell deat”
TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMS
Wallach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko, A. V., & Boldin, M. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.331 · Cited by 1,312 · cited 10×
“2f), whereas it completely inhibited the appearance of necrotic morphology (nuclear condensation, organelle swelling, early loss of plasma membrane integrity and Nec-1 0 20 40 60 80 100 V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% )…”
InfluentialIntracellular ATP levels determine cell death fate by apoptosis or necrosis.
Eguchi, Y., Shimizu, S., & Tsujimoto, Y. (1997) · PubMed · Cited by 1,243
Cited by
Items 901–1,000 of 1,015
Ma, Y., Peng, Y.-M., Zhu, Q., Gao, A., Chao, B., He, Q., Li, J., Hu, Y., & Zhou, Y. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.61 · Cited by 63
Qiu, X., Zhang, Y., & Han, J. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0075-x · Cited by 62
“The current nomenclature defines necroptosis as cell death mediated by signaling transduction from receptor interacting protein (RIP) 1 to RIP3 [1].”
BackgroundAguirre, J. I., Castillo, E. J., & Kimmel, D. B. (2021) · Bone · doi:10.1016/j.bone.2021.116168 · Cited by 72
“The form of RCD displaying a necrotic cell death phenotype was named “necroptosis”[143].”
BackgroundInfluentialTehranian, R., Rose, M. E., Vagni, V., Pickrell, A. M., Griffith, R. P., Liu, H., Clark, R. S. B., Dixon, C. E., Kochanek, P. M., & Graham, S. H. (2008) · Journal of Neurotrauma · doi:10.1089/neu.2007.0441 · Cited by 62
“Furthermore, cell death with necrotic morphology may be mediated by activation of apoptotic pathways as Fas or TNF (cid:2) under certain conditions (Degterev et al., 2005).”
Multiple death pathways in TNF-treated fibroblasts: RIP3- and RIP1-dependent and independent routes
Zhang, D., Zheng, M., Zhao, J., Li, Y.-Y., Huang, Z., Li, Z., & Han, J. (2011) · Cell Research · doi:10.1038/cr.2011.3 · Cited by 70
Self-citationLee, M.-J., Kao, S., Hunag, J.-E., Sheu, G., Yeh, C., Hseu, Y., Wang, C., & Hsu, L. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.01.008 · Cited by 62
“Nec-1 is a small molecule that exhibits inhibitory effects of receptor-interacting protein-1 (RIP-1) by binding to the T-loop, and functions as a specific inhibitor of necroptosis, but not apoptosis [30,31].”
BackgroundDNase γ Is the Effector Endonuclease for Internucleosomal DNA Fragmentation in Necrosis
Mizuta, R., Araki, S., Furukawa, M., Furukawa, Y., Ebara, S., Shiokawa, D., Hayashi, K., Tanuma, S.-I., & Kitamura, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080223 · Cited by 65
“Next we utilized the U937 human hystiocytic leukemia cell line, which is known to undergo apoptosis upon treatment with TNF-a in the presence of cycloheximide (CHX), but necrosis in the additional presence of Z-VAD-fmk, a pan-caspase inhibitor [21].”
MethodLi, G., Fan, B., & ZHENG, Y.-C. (2010) · Biomedical and Environmental Sciences · doi:10.1016/s0895-3988(10)60078-5 · Cited by 65
Guan, J., & Gluckman, P. D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00256.x · Cited by 69
“Delayed neuronal/glial injury can be mediated through necrotic, apoptotic and necroptotic pathways (Degterev et al., 2005); although the downstream cascades of these cell death pathways largely overlap (Yuan et al.”
BackgroundScreening for chemicals that affect hair cell death and survival in the zebrafish lateral line
Ou, H. C., Simon, J. A., Rubel, E. W., & Raible, D. W. (2012) · Hearing Research · doi:10.1016/j.heares.2012.01.009 · Cited by 65
“…by an understanding that apoptosis and necrosis are two extremes in a continuum of cell death mechanisms (reviewed in Vandenabeele et al., 2010), and that necrosis in some cases is a carefully regulated process similar to apoptosis (Holler et al., 2000; Degterev et al., 2005; Hitomi et al., 2008).”
Xiao, X., Du, C., Yan, Z., Shi, Y., Duan, H., & Ren, Y. (2017) · American Journal of Nephrology · doi:10.1159/000478746 · Cited by 63
Necroptosis Signaling Pathways in Stroke: From Mechanisms to Therapies
Huang, J., Li, Y., Zhao, B.-L., Li, J., Zhang, N., Ye, Z., Xue-Jun, S., & Wen-wu, L. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180416152243 · Cited by 65
“Furthermore, Nec-1 has a longer-time window in contrast of Z-VAD-fmk, an inhibitor of apoptosis [24].”
BackgroundInfluentialSelf-citationZhang, H., Xu, L., Qin, X., Chen, X., Cong, H., Hu, L., Chen, L., Miao, Z., Zhang, W., Cai, Z., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00611 · Cited by 65
Li, X., Cheng, S., Hu, H., Zhang, X., Xu, J., Wang, R., & Zhang, P. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.09.111 · Cited by 61
TRADD Mediates RIPK1-Independent Necroptosis Induced by Tumor Necrosis Factor
Wang, L., Chang, X., Feng, J., Yu, J., & Chen, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00393 · Cited by 69
Cell death inhibitors protect against brain damage caused by cardiac ischemia/reperfusion injury
Liao, S., Apaijai, N., Luo, Y., Wu, J., Chunchai, T., Singhanat, K., Arunsak, B., Benjanuwattra, J., Chattipakorn, N., & Chattipakorn, S. C. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00698-4 · Cited by 62
Proapoptotic effects of NARC 1 (= PCSK9), the gene encoding a novel serine proteinase
Bingham, B., Shen, R., Kotnis, S., Lo, C. F., Ozenberger, B. A., Ghosh, N., Kennedy, J. D., Jacobsen, J. S., Grenier, J. M., DiStefano, P. S., et al. (2006) · Cytometry Part A · doi:10.1002/cyto.a.20346 · Cited by 60
“ning the range from necrosis to apoptosis (29,30).”
BackgroundYashin, D. V., Ivanova, O. K., Soshnikova, N. V., Sheludchenkov, A. A., Romanova, E. A., Dukhanina, E. A., Tonevitsky, A., Gnuchev, N. V., Gabibov, A. G., Georgiev, G. P., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.639732 · Cited by 61
“An alternative character of cell death is described for the death receptors (14).”
BackgroundZhang, H., Wei, M., Lu, X., Sun, Q., Wang, C., Zhang, J., & Fan, H. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.136942 · Cited by 59
Targeting regulated cell death in aortic aneurysm and dissection therapy
Chen, Y., He, Y., Wei, X., & Jiang, D. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.106048 · Cited by 61
Emerging therapies to target CNS pathophysiology in multiple sclerosis
Oh, J., & Bar‐Or, A. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00675-0 · Cited by 66
Taccola, G., Margaryan, G., Mladinić, M., & Nistri, A. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.008 · Cited by 68
Past, Present, and Future of Molecular and Cellular Oncology
Galluzzi, L., Vitale, I., & Kroemer, G. (2011) · Frontiers in Oncology · doi:10.3389/fonc.2011.00001 · Cited by 66
Necrosis-like death can engage multiple pro-apoptotic Bcl-2 protein family members
Tischner, D., Manzl, C., Soratroi, C., Villunger, A., & Krumschnabel, G. (2012) · Apoptosis · doi:10.1007/s10495-012-0756-8 · Cited by 60
“[6] described induction of autophagy as a downstream event of necroptotic stimuli, but could also not see cytoprotection by 3-MA or in autophagy-deficient MEF.”
InfluentialMolecular Cell Biology of Apoptosis and Necroptosis in Cancer
Dillon, C. P., & Green, D. R. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-39406-0_1 · Cited by 66
Romero, A., Ramos, E., Arés, I., Castellano, V., Martínez, M., Martínez‐Larrañaga, M., Anadón, A., & Martínez, M. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1864-y · Cited by 66
Nikseresht, S., Khodagholi, F., & Ahmadiani, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27055 · Cited by 58
“Emerging evidence on Tumor necrosis factor receptor (TNFR) potential to induce both apoptosis and necrosis in 1988 (Laster et al., 1988) paved the way for discovery of necroptosis in 2005 (Degterev et al., 2005).”
Cellular Stress and General Pathological Processes
Gusev, E. Y., & Zotova, N. V. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190319114641 · Cited by 69
From (Tool)Bench to Bedside: The Potential of Necroptosis Inhibitors
Gardner, C. R., Davies, K. A., Zhang, Y., Brzozowski, M., Czabotar, P. E., Murphy, J. M., & Lessène, G. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01621 · Cited by 60
Abhari, B. A., Cristofanon, S., Kappler, R., von Schweinitz, D., Humphreys, R. C., & Fulda, S. (2012) · Oncogene · doi:10.1038/onc.2012.337 · Cited by 64
Hypoxia Ischemia-Mediated Cell Death in Neonatal Rat Brain
Gill, M. B., & Perez-Polo, J. R. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9649-1 · Cited by 70
“Although there are reports on how specific models induce specific pathways, such as DNA methylating agents applied to primary cortical neurons [39, 49, 53, 55], very few common themes have emerged.”
BackgroundNecrostatin-1 Reduces Neurovascular Injury after Intracerebral Hemorrhage
King, M. D., Whitaker-Lea, W. A., Campbell, J. M., Alleyne, C. H., & Dhandapani, K. M. (2014) · International Journal of Cell Biology · doi:10.1155/2014/495817 · Cited by 61
Targeting Mitochondria in Fighting Cancer
Gogvadze, V. G. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798764933 · Cited by 65
“One of these modes of cell death called necroptosis has recently been described [7].”
BackgroundNecroptosis in Niemann–Pick disease, type C1: a potential therapeutic target
Cougnoux, A., Cluzeau, C., Mitra, S., Li, R., Williams, I., Burkert, K., Xu, X., Wassif, C. A., Zheng, W., & Porter, F. D. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.16 · Cited by 57
“Treatment with Nec1 was reported to be neuroprotective in NMDAmediated excitotoxicity(25) and cerebral ischemia.(26) Furthermore, it has been shown to be efficacious to target the necroptosis pathway in mouse models of Huntington disease(23) and amyotrophic lateral sclerosis.”
BackgroundHomeostatic interplay between electrical activity and neuronal apoptosis in the developing neocortex
Blanquie, O., Kilb, W., Sinning, A., & Luhmann, H. J. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.06.030 · Cited by 62
Intracellular Peptides in Cell Biology and Pharmacology
de Araujo, C. B., Heimann, A. S., Remer, R. A., Russo, L. C., Colquhoun, A., Forti, F. L., & Ferro, E. S. (2019) · Biomolecules · doi:10.3390/biom9040150 · Cited by 63
“A combination of necrostatin-1, an inhibitor of necroptosis [132], and qVD, a potent caspase inhibitor, protects cells from death by Pep5-cpp [133].”
BackgroundA unique bacterial tactic to circumvent the cell death crosstalk induced by blockade of caspase‐8
Ashida, H., Sasakawa, C., & Suzuki, T. (2020) · The EMBO Journal · doi:10.15252/embj.2020104469 · Cited by 61
“…a mitochondria-mediated or receptor-mediated pathway, whereas pyroptosis and necroptosis are lytic forms of cell death that require caspase-1/-4 – GSDMD and RIPK3 – MLKL signaling, respectively (Kerr et al , 1972; Holler et al , 2000; Degterev et al , 2005; Kayagaki et al , 2015; Shi et al , 2015).”
Remodeling of the Neurovascular Unit Following Cerebral Ischemia and Hemorrhage
Satō, Y., Falcone-Juengert, J., Tominaga, T., Su, H., & Liu, J. (2022) · Cells · doi:10.3390/cells11182823 · Cited by 64
Stress/cell death pathways, neuroinflammation, and neuropathic pain
Li, L., Li, T. X., Qu, X., Sun, G., Fu, Q., & Han, G. (2023) · Immunological Reviews · doi:10.1111/imr.13275 · Cited by 59
Sakamaki, K., Imai, K., Tomii, K., & Miller, D. J. (2015) · BioEssays · doi:10.1002/bies.201500010 · Cited by 66
Kochanek, P. M., Bramlett, H., Dietrich, W. D., Dixon, C. E., Hayes, R. L., Povlishock, J., Tortella, F. C., & Wang, K. K. W. (2011) · Journal of Trauma: Injury, Infection & Critical Care · doi:10.1097/ta.0b013e31822117fe · Cited by 58
Anticancer Agent Shikonin Is an Incompetent Inducer of Cancer Drug Resistance
Wu, H., Xie, J., Pan, Q., Wang, B., Hu, D., & Hu, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052706 · Cited by 59
“1) could circumvent cancer drug resistance mediated by drug transporters P-glycoprotein (P-gp), multidrug resistance-associated protein 1 (MRP1), and brest cancer resistance protein (BCRP1), and by antiapoptotic proteins Bcl-2 and Bcl-xL, by induction of necroptosis [22,23,24,25,26], a cell death recently defined and…”
BackgroundDragovic, S., Vermeulen, N. P. E., Gerets, H. H., Hewitt, P. G., Ingelman‐Sundberg, M., Park, B. K., Juhila, S., Snoeys, J., & Weaver, R. J. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1845-1 · Cited by 58
“Recent research suggests necrosis, in part, is mediated through programmed cell death (necroptosis) through activation by tumour necrosis factor alpha (TNFα), Fas ligand (FasL) and tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) by ligands also implicated in apoptosis (Degterev et al. 2005).”
BackgroundIschemia Reperfusion Injury Triggers TNFα Induced-Necroptosis in Rat Retina
Kim, C. R., Kim, J. H., Park, H.-Y. L., & Park, C. K. (2017) · Current Eye Research · doi:10.1080/02713683.2016.1227449 · Cited by 57
“To verify the inhibition of necroptosis in IR-injured retinas, Nec-1 was injected intravitreally.(23,24,38,39) The IHC results showed a decreased expression of RIP1 in GCL.”
MethodZhang, L., Feng, Q., & Wang, T. (2018) · Cardiovascular Toxicology · doi:10.1007/s12012-017-9441-z · Cited by 59
Liu, X., Zhang, L., Gao, H., Hou, Y., Lu, J., Feng, Y., Xu, Q., Liu, B., & Chen, X. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113684 · Cited by 59
Distinguishing between apoptosis, necrosis, necroptosis and other cell death modalities
Martin, S. J., & Henry, C. M. (2013) · Methods · doi:10.1016/j.ymeth.2013.06.001 · Cited by 70
Tojo, K., Tamada, N., Nagamine, Y., Yazawa, T., Ota, S., & Goto, T. (2018) · The FASEB Journal · doi:10.1096/fj.201700888r · Cited by 60
“Cell death was not suppressed by the caspase 3/7 inhibitor but was markedly suppressed by necrostatin-1 (20)”
BackgroundSomeda, M., Kuroki, S., Miyachi, H., Tachibana, M., & Yonehara, S. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0434-2 · Cited by 59
Aging-Dependent Mitophagy Dysfunction in Alzheimer’s Disease
Song, M., Zhao, X., & Song, F. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02248-y · Cited by 60
RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease
Afonso, M. B., Islam, T., Magusto, J., Amorim, R., Lenoir, V., Simões, R. F., Teixeira, J., Silva, L. C., Wendum, D., Jéru, I., et al. (2022) · Hepatology · doi:10.1002/hep.32756 · Cited by 60
“[16] However, the role of ROS in necroptosis execution might be cell- and context- dependent,[17] and mitochondrial depletion via mitophagy does not halt necroptotic cell death.”
BackgroundProtein amyloid aggregate: Structure and function
Xu, Q., Ma, Y., Sun, Y., Li, D., Zhang, X., & Liu, C. (2023) · Aggregate · doi:10.1002/agt2.333 · Cited by 71
Norovirus MLKL-like protein initiates cell death to induce viral egress
Wang, G., Zhang, D., Orchard, R. C., Hancks, D. C., & Reese, T. A. (2023) · Nature · doi:10.1038/s41586-023-05851-w · Cited by 61
Galindo, C. L., Khan, S. R., Zhang, X., Yeh, Y., Liu, Z., & Razani, B. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2288272 · Cited by 61
Liao, D., Sun, L., Liu, W., He, S., Wang, X., & Lei, X. (2014) · MedChemComm · doi:10.1039/c3md00278k · Cited by 60
Hernández, L. A. P., Kim, M.-K., Noonan, A. M., Sagher, E., Kohlhammer, H., Wright, G. W., Lyle, L. T., Steeg, P. S., Anver, M. R., Bowtell, D. D. L., et al. (2015) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.53 · Cited by 61
Peroxiredoxins and the Regulation of Cell Death
Hampton, M. B., & O'Connor, K. M. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.2351 · Cited by 62
“Pore formation is controlled by the proand anti-apoptotic members of the Bcl-2 family that initiates Molecules and Cells http://molcells.org Established in 1990 eISSN: 0219-1032 The Korean Society for Molecular and Cellular Biology.”
BackgroundBeyond VEGF—The Weisenfeld Lecture
Miller, J. W. (2016) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.16-21201 · Cited by 54
“However, recent studies indicate that necrosis can be regulated, induced by regulated signal transduction pathways such as receptor-interacting protein (RIP) kinases.(26,27) We looked for evidence of programmed necrosis, or necroptosis, in photoreceptor cell death.”
BackgroundRIPK1–RIPK3–MLKL-Associated Necroptosis Drives Leishmania infantum Killing in Neutrophils
Barbosa, L. A., Fiuza, P. P., Borges, L. J., Rolim, F. A., Andrade, M. B., Luz, N. F., Carvalho, G. Q., Lima, J. B., de Almeida, R. P., Chan, F. K., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01818 · Cited by 61
“Necrosulfonamide (NSA) is an effective pharmacological inhibitor of human MLKL (33, 35).”
BackgroundGilbert, S. J., Singhrao, S. K., Khan, I. M., Gonzalez, L. G., Thomson, B. M., Burdon, D., Duance, V. C., & Archer, C. W. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2008.0361 · Cited by 56
Exploiting metabolic cell death for cancer therapy
Mao, C., Jiang, D., Koong, A. C., & Gan, B. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00879-8 · Cited by 81
Cancer cell death: Cell-autonomous and immunogenic dimensions
Galluzzi, L., Kepp, O., Zitvogel, L., Tang, D., & Kroemer, G. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.12.005 · Cited by 76
Systems biology of yeast cell death
Munoz, A. J., Wanichthanarak, K., Meza, E., & Petranović, D. (2011) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2011.00781.x · Cited by 62
Ning, Y., Shi, Y., Chen, J., Song, N., Cai, J., Fang, Y., Yu, X., Ji, J., & Ding, X. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00384 · Cited by 56
“In 2005, Degterev and colleagues identified that the 5-(1H-indol-3-ylmethyl)-2-thiohydantoin 1, called Necrostatin-1 (Nec-1), could specifically inhibit RIP1 kinase and then inhibit RIP-mediated necroptosis (Degterev et al., 2005, 2008).”
BackgroundChen, T., Pan, H., Li, J., Xu, H., Jin, H., Qian, C., Yan, F., Chen, J., Wang, C., Chen, J., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.056 · Cited by 56
Huang, X., Xiao, F., Li, Y., Qian, W., Ding, W., & Ye, X. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0976-z · Cited by 62
Self-citationInterleukin-1α and brain inflammation
Brough, D., & Denes, A. (2015) · IUBMB Life · doi:10.1002/iub.1377 · Cited by 54
Zhu, J., Xin, M., Xu, C., He, Y., Zhang, W., Wang, Z., & Zhuang, C. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.017 · Cited by 54
Cell death affecting the progression of gastric cancer
Wang, H., Liu, M., Zeng, X., Zheng, Y., Wang, Y., & Zhou, Y. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01161-8 · Cited by 60
“used a large-scale drug screen to find drugs that could inhibit RIPK1-mediated programmed necrosis, and they found that Necrostatin-1 (Nec-1) could inhibit TNF+ z-VAD (inhibitor of caspases)-induced programmed necrosis in a variety of cells, and named this caspase-independent programmed necrosis necroptosis [33].”
BackgroundJin, X., Jin, W., Tong, L., Zhao, J., Zhang, L., & Lin, N. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.04.020 · Cited by 64
“…serine/threonine kinases 1 and 3 (RIPK1, RIPK3), and the executioner protein mixed lineage kinase domain-like pseudokinase (MLKL), and RIPK1 is often ubiquitinated by cellular inhibitors of apoptosis (cIAP1/2) and linear ubiquitin chain assembly complex (LUBAC) or cylindromatosis (CYLD) 18 .”
InfluentialNecrostatin-1 inhibits Hmgb1-IL-23/IL-17 pathway and attenuates cardiac ischemia reperfusion injury
Zhang, A., Mao, X., Li, L., Tong, Y., Huang, Y., Lan, Y., & Jiang, H. (2014) · Transplant International · doi:10.1111/tri.12349 · Cited by 54
“cally inhibit the pro-necrotic kinase function of RIP1 [8].”
BackgroundRIP Kinase-Mediated Necrosis as an Alternative Mechanism of Photoreceptor Death
Murakami, Y., Miller, J. W., & Vavvas, D. G. (2011) · Oncotarget · doi:10.18632/oncotarget.286 · Cited by 60
“This programmed form of necrosis is termed programmed necrosis or necroptosis [24,25].”
BackgroundNecroptosis in acute kidney injury: a shedding light
Wang, S., Zhang, C., Hu, L., & Yang, C. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.37 · Cited by 55
“As the identification of necrostatins as specific inhibitors targeting receptor-interacting protein kinase 1 (RIP1), the signaling pathways of necroptosis have been extensively determined.(14,15) Engagement of death receptors and Toll-like receptors (TLRs), interferon (IFN) signals, as well as intracellular stimuli fr…”
BackgroundNecrostatin-1 protects against oleic acid-induced acute respiratory distress syndrome in rats
Pan, L., Yao, D.-C., Yu, Y.-Z., Li, S., Chen, B.-J., Hu, G.-H., Xi, C., Wang, Z., Wang, H., Li, J., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.163 · Cited by 54
Mechanical force-mediated pathological cartilage thinning is regulated by necroptosis and apoptosis
Zhang, C., Lin, S., Li, T., Jiang, Y., Huang, Z., Wen, J., Cheng, W., & Li, H. (2017) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2017.03.018 · Cited by 54
Self-citationValproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells
Aztopal, N., Erkısa, M., Ertürk, E., Ulukaya, E., Tokullugil, A., & Arı, F. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.12.003 · Cited by 58
Tozasertib Analogues as Inhibitors of Necroptotic Cell Death
Hofmans, S., Devisscher, L., Martens, S., Rompaey, D. V., Goossens, K., Divert, T., Nerinckx, W., Takahashi, N., Winter, H. L. D., der Veken, P. V., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01449 · Cited by 58
Zhan, L., Lü, Z., Zhu, X., Xu, W., Li, L., Li, X., Chen, S., Sun, W., & Xu, E. (2018) · The FASEB Journal · doi:10.1096/fj.201800111rr · Cited by 54
“In addition, necroptosis has been reported to be involved in several different types of cerebral ischemic injury (5, 6, 38).”
BackgroundBAD sensitizes breast cancer cells to docetaxel with increased mitotic arrest and necroptosis
Mann, J. K., Yang, N., Montpetit, R., Kirschenman, R. D., Lemieux, H., & Goping, I. S. (2020) · Scientific Reports · doi:10.1038/s41598-019-57282-1 · Cited by 57
Molecular mechanisms of necroptosis and relevance for neurodegenerative diseases.
(2020) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2019.12.006 · Cited by 51
Zhang, L., Cheng, D., Zhang, J., Tang, H., Li, F., Peng, Y., Duan, X., Meng, E., Zhang, C., Zeng, T., et al. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.131262 · Cited by 56
Necroptosis inhibitors: mechanisms of action and therapeutic potential
Zhou, Y., Cai, Z., Zhai, Y., Yu, J., He, Y., He, Y., Jitkaew, S., & Cai, Z. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01905-6 · Cited by 61
“The first necroptosis inhibitor Necrostatin-1 (Nec-1) was discovered by Degterev et al. in 2005 [31], and it was later identified as a specific inhibitor of RIPK1 [32].”
Loss of Caspase-3 sensitizes colon cancer cells to genotoxic stress via RIP1-dependent necrosis
Brown, M. F., Leibowitz, B. J., Chen, D., He, K., Zou, F., Sobol, R. W., Beer–Stolz, D., Zhang, L., & Yu, J. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.104 · Cited by 59
“5-FU-induced HMGB1 release (Figures 5b–c) and the PI+/Annexin V- population (Figure 5d) in C3KO cells were significantly suppressed when RIP1 was inhibited by short-hairpin RNA (shRNA), kinase domain deleted RIP1, or the small molecule inhibitor necrostatin-1 (Nec-1).(22) The MLKL inhibitor necrosulfonamide (NSA)(15)…”
Polito, L., Bortolotti, M., Pedrazzi, M., Mercatelli, D., Battelli, M. G., & Bolognesi, A. (2015) · Phytomedicine · doi:10.1016/j.phymed.2015.11.006 · Cited by 53
Post-translational control of RIPK3 and MLKL mediated necroptotic cell death
Murphy, J. M., & Vince, J. E. (2015) · F1000Research · doi:10.12688/f1000research.7046.1 · Cited by 59
Zhang, P., Deng, Y.-H., He, H.-Y., & Yang, L. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.187045 · Cited by 55
“Indeed, it has been reported that treatment with inhibitors of autophagy significantly decreases brain damage, and activation of autophagy in cerebral ischemia results in a negative outcome (Degterev et al., 2005; Descloux et al., 2015).”
Tanzer, M. C., Khan, N. R., Rickard, J. A., Etemadi, N., Lalaoui, N., Spall, S. K., Hildebrand, J. M., Segal, D., Miasari, M., Chau, D., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2016.147 · Cited by 56
“To assess whether this caspase-independent cell death was necroptosis, we inhibited RIPK1 using Nec-1.”
MethodWang, Q., Zhou, T., Liu, Z., Ren, J. P., Phan, N., Gupta, K., Stewart, D. M., Morgan, S., Assa, C. R., Kent, K. C., et al. (2017) · Scientific Reports · doi:10.1038/srep42159 · Cited by 60
Chemically different non-thermal plasmas target distinct cell death pathways
Lunov, O., Zablotskii, V., Churpita, O., Lunová, M., Jirsa, M., Dejneka, A., & Kubinová, Š. (2017) · Scientific Reports · doi:10.1038/s41598-017-00689-5 · Cited by 55
Flamme, M., Cressey, P., Lü, C., Bruno, P. M., Eskandari, A., Hemann, M. T., Hogarth, G., & Suntharalingam, K. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201701837 · Cited by 54
Necroptosis: A novel manner of cell death, associated with stroke (Review)
Liu, C., Zhang, K., Shen, H., Yao, X., Sun, Q., & Chen, G. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3279 · Cited by 64
“A recent study showed, however, that necrosis can also be regulated in a programmed manner (3).”
InfluentialOmoruyi, S. I., Ekpo, O. E., Semenya, D. M., Jardine, A., & Prince, S. (2020) · Apoptosis · doi:10.1007/s10495-020-01594-5 · Cited by 53
Jinawong, K., Apaijai, N., Wongsuchai, S., Pratchayasakul, W., Chattipakorn, N., & Chattipakorn, S. C. (2020) · Diabetes · doi:10.2337/db19-1128 · Cited by 53
“It shares similar mechanisms and morphology with both apoptosis and necrosis (9).”
BackgroundInfluentialLi, J., Huang, S., Zeng, L., Li, K., Yang, L., Gao, S., Guan, C., Zhang, S., Lao, X., Liao, G., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2538-5 · Cited by 57
The injury response to DNA damage in live tumor cells promotes antitumor immunity
Sriram, G., Milling, L. E., Chen, J.-K., Kong, Y. W., Joughin, B. A., Abraham, W. D., Swartwout, S., Handly, E. D., Irvine, D. J., & Yaffe, M. B. (2021) · Science Signaling · doi:10.1126/scisignal.abc4764 · Cited by 56
“Despite the known importance of RIPK1 activity in promoting nonapoptotic cell death (59, 60), we did not observe significant amounts of necroptotic cell death.”
BackgroundLiu, L., Huang, L., Chen, W., Zhang, G., Li, Y., Wu, Y., Xiong, J., & Jie, Z. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.811269 · Cited by 63
“With additional research, another mechanism of cell death, necroptosis (programmed necrosis), was discovered in 1988 as a type of programmed death and was named in 2005 (Laster et al., 1988; Degterev et al., 2005).”
BackgroundSelf-citationMolecular mechanisms of cell death in bronchopulmonary dysplasia
Deng, X., Bao, Z., Yang, X., Mei, Y., Zhou, Q., Chen, A., Yu, R., & Zhang, Y. (2022) · APOPTOSIS · doi:10.1007/s10495-022-01791-4 · Cited by 60
Zhao, X., Zhang, J., Zhang, W., Guo, Z., Wei, W., Wang, X., & Zhao, J. (2023) · Chemical Science · doi:10.1039/d2sc06171f · Cited by 53
ALDH7A1 protects against ferroptosis by generating membrane NADH and regulating FSP1
Yang, J., Morris, A. J., Kamizaki, K., Chen, J., Stark, J., Oldham, W. M., Nakamura, T., Mishima, E., Loscalzo, J., Minami, Y., et al. (2025) · Cell · doi:10.1016/j.cell.2025.03.019 · Cited by 63
Intrinsic cleavage of receptor-interacting protein kinase-1 by caspase-6
van Raam, B. J., Ehrnhoefer, D. E., Hayden, M. R., & Salvesen, G. S. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.98 · Cited by 59
Metadata
- Authors
- Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Tokyo Metropolitan Institute of Medical Science (JP)
- Corresponding author
- Yuan, Junying
- ORCID
- Venue
- Nature Chemical Biology
- Published
- 2005-05-29
- Volume
- 1
- Issue
- 2
- Pages
- 112-119
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W2110796758
- Cited by
- 3,068
- References
- 39
- Citations by year
- 2026: 144 · 2025: 217 · 2024: 239 · 2023: 240 · 2022: 237 · 2021: 208 · 2020: 181 · 2019: 150 · 2018: 190 · 2017: 171 · 2016: 161 · 2015: 150 · 2014: 180 · 2013: 126 · 2012: 111
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Update notices
- addendum (2013-02-15)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Chemical Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Health Assistance Foundation
- National Institute on Aging (R37AG012859)
- National Institute of General Medical Sciences (R01GM064703, R01 GM64703)
- National Institute of Neurological Disorders and Stroke (R01NS037141, R01 NS37141-08)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- necroptosis, non-apoptotic cell death, necrostatin-1, ischemic brain injury, stroke, neuroprotection, autophagy, regulated cell death, small molecule inhibitors
- MeSH terms
- Animals, Brain Ischemia, Humans, Imidazoles, Indoles, Molecular Structure, Signal Transduction, Cell Death, Protein Serine-Threonine Kinases, Cell Line, Tumor, Protein Kinase Inhibitors, Tumor Necrosis Factor Receptor-Associated Peptides and Proteins, Mice, Receptor-Interacting Protein Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.